Multiple Sclerosis Clinical Trial
— SMSROfficial title:
Swiss Multiple Sclerosis Registry
NCT number | NCT02980640 |
Other study ID # | PB_2016-00894 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 2016 |
Est. completion date | June 2041 |
The Swiss Multiple Sclerosis Registry is a national, patient-centered registry with the aim to document the epidemiology of multiple sclerosis (MS), as well as the quality of life of persons living with MS in Switzerland.
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | June 2041 |
Est. primary completion date | June 2041 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Persons with a confirmed Multiple Sclerosis Diagnosis - 18 years and older - Living in Switzerland or receiving MS care in Switzerland Exclusion Criteria: - Younger than 18 years - Not living in Switzerland and not receiving MS care in Switzerland |
Country | Name | City | State |
---|---|---|---|
Switzerland | University of Zurich; Epidemiology, Biostatistics & Prevention Institute | Zurich |
Lead Sponsor | Collaborator |
---|---|
Swiss Multiple Sclerosis Registry | Schweizerische Multiple Sklerose Gesellschaft, University of Zurich, Epidemiology, Biostatistics and Prevention Institute |
Switzerland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Health-Related Quality of Life | Assessment via EQ-5D | Baseline; 6, 12, 18, 24, 30, 36, 42, 48, 54, 60 months | |
Primary | Change in Self-Assessment of Health Status | Assessment via Visual Analogue Scale | Baseline; 6, 12, 18, 24, 30, 36, 42, 48, 54, 60 months | |
Secondary | Occurrence of MS Symptoms | Self-report of new and recurrent MS symptoms | Baseline; 6, 12, 18, 24, 30, 36, 42, 48, 54, 60 months | |
Secondary | Occurrence of Adverse Drug Effects | Self-report of unwanted drug side effects | Baseline; 6, 12, 18, 24, 30, 36, 42, 48, 54, 60 months | |
Secondary | Occurrence of MS Relapse | Self-report of MS relapse(s) | Baseline; 6, 12, 18, 24, 30, 36, 42, 48, 54, 60 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
Completed |
NCT02845635 -
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
|